SAN DIEGO--(BUSINESS WIRE)--Santarus, Inc. (NASDAQ:SNTS), a specialty biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved the company’s New Drug ...
Omeprazole (Procid - 20 ) is a proton pump inhibitor, prescribed for indigestion, peptic ulcer and gastroesophageal reflux disease (GORD/GERD). It works by decreasing stomach acid production. The ...
Omeprazole (Biocid ) is a proton pump inhibitor, prescribed for indigestion, peptic ulcer and gastroesophageal reflux disease (GORD/GERD). It works by decreasing stomach acid production. The ...
Mumbai, Aug. 8 -- This product is bioequivalent to the reference listed drug (RLD), Prilosec Delayed-Release Tablets, 20 mg (OTC), marketed by AstraZeneca Pharmaceuticals LP under NDA 021229.
Current guidelines recommend that patients at risk for ulcer disease who require treatment for arthritis receive nonsteroidal antiinflammatory drugs (NSAIDs) that are selective for cyclooxygenase-2 or ...
Omeprazole ranks amongst the most frequently prescribed medications in the UK, with the latest figures revealing 73 million NHS prescriptions for proton pump inhibitors (PPIs), such as Omeprazole, ...
Outcome of Patients Receiving Radiation for Cancer of the Esophagus: Results of the 1992-1994 Patterns of Care Study PURPOSE: Anticancer drugs may induce acute mucosal injury to stomach and duodenum.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback